Escherichia Coli

Image: iStock/Karisssa

Astellas to develop rice-based oral cholera vaccine

By Phil Taylor

Japan's Astellas has agreed to carry out clinical trials of a vaccine for serious diarrhoeal diseases which does not need to be refrigerated or injected and is produced in transgenic rice plants.

Avecia takes on new MS drug

Avecia takes on new MS drug

By staff reporter

Avecia Biologics has signed a development and manufacturing deal
with US firm BaroFold, making use of the company's protein
processing technology to produce its lead interferon-based multiple
sclerosis (MS) candidate.


Follow us


View more


Featured Suppliers